CN102266447B - Chinese medicinal composition for treating coronary heart disease - Google Patents
Chinese medicinal composition for treating coronary heart disease Download PDFInfo
- Publication number
- CN102266447B CN102266447B CN201110242242A CN201110242242A CN102266447B CN 102266447 B CN102266447 B CN 102266447B CN 201110242242 A CN201110242242 A CN 201110242242A CN 201110242242 A CN201110242242 A CN 201110242242A CN 102266447 B CN102266447 B CN 102266447B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- root
- grams
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 17
- 239000000203 mixture Substances 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 241000628997 Flos Species 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 11
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 238000007689 inspection Methods 0.000 abstract description 4
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 240000008564 Boehmeria nivea Species 0.000 abstract 1
- 244000140995 Capparis spinosa Species 0.000 abstract 1
- 235000017336 Capparis spinosa Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000735527 Eupatorium Species 0.000 abstract 1
- 241000221079 Euphorbia <genus> Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241001412178 Rubus pluribracteatus Species 0.000 abstract 1
- 241000530742 Salix elaeagnos Species 0.000 abstract 1
- 240000001398 Typha domingensis Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000007902 hard capsule Substances 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010003225 Arteriospasm coronary Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 208000003890 Coronary Vasospasm Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 201000011634 coronary artery vasospasm Diseases 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 208000023482 precordial pain Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal composition for treating a coronary heart disease. The Chinese medicinal composition is prepared from the following raw materials in parts by weight: 7-9 parts of sun euphorbia herb, 5-7 parts of bitter willow root, 7-9 parts of acuteleaf caper root, 7-9 parts of rubus pluribracteatus, 13-15 parts of astragalus root, 10-14 parts of cattail pollen, 8-10 parts of safflower, 9-11 parts of szechuan lovage rhizome, 9-11 parts of Chinese angelica, 10-14 parts of cassia twig, 5-7 parts of fortune eupatorium herb, 9-11 parts of red paeony root, 9-11 parts of liquoric root, 9-11 parts of ramie root and 13-17 parts of rehmannia root. The Chinese medicinal composition has the advantages of effects of treating both principal and secondary aspects of a disease, no toxic or side effect, convenience for taking, easiness for absorbing, quick response, good curative effect, low price and quick action, is consistent with relevant national standard as provided by inspection, and has quick response as proved by clinical application observation. Compared with the conventional medicament for treating the coronary heart disease, the Chinese medicinal composition has the characteristics of long acting, quick acting and high efficiency.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition of treating coronary heart disease.
Background technology
Coronary heart disease be in, the frequently-occurring disease in the elderly population, mainly due to coronary atherosclerosis, the coronary vasospasm that causes of risk factor makes the temporary transient aggravation of myocardial ischemia and causes angina pectoris in addition, severe patient can show myocardial infarction, arrhythmia etc.
Coronary heart disease belongs to categories such as motherland's medical science " thoracic obstruction ", " angina pectoris ", " precordial pain with cold limbs ", motherland's medical science think primary disease generation and aged debility, deficiency of kidney-QI, greasy and surfeit flavour, spleen injury, internal injury caused by excess of seven emotions, qi depression to blood stasis, thinking overstrain, to injure factors such as heart spleen relevant.Point out simultaneously in the pathogenic process of primary disease, the heart, spleen, suffer from a deficiency of the kidney be disease this, and the stagnation of QI, blood stasis, expectorant are turbid, the numbness resistance is the mark of disease.Mostly clinical be the double mutually appearance of vital QI being weakened and pathogen being violent, deficiency and excess.The treatment of coronary heart disease should by deficiency and excess in addition dialectical executing control, adopt the dialectical method that combines with differential diagnosis of diseases, normal " benefits " and " leading to " two big rules of adopting are main at acute attack stage to take stopgap measures, it is auxilliary effecting a permanent cure, and is main in the catabasis to effect a permanent cure, it is auxilliary taking stopgap measures.Treat to consolidate curative effect with the method for effecting a permanent cure after the stable disease.
Summary of the invention
The present invention is in order to remedy the deficiency of prior art, provides that a kind of good effect, instant effect, treating both the principal and secondary aspects of a disease, expense are low, the Chinese medicine composition of the treatment coronary heart disease that has no side effect.
The present invention realizes through following technical scheme:
The Chinese medicine composition of treatment coronary heart disease of the present invention, its special character is: the raw material by following parts by weight is processed: Rhizoma Arisaematis 7-9 part, Radix Salicis Purpureae 5-7 part, Herba Moslae Cavaleriei 7-9 part; Radix Rubi Multibracteati 7-9 part, Radix Astragali 13-15 part, Pollen Typhae 10-14 part, Flos Carthami 8-10 part; Rhizoma Chuanxiong 9-11 part, Radix Angelicae Sinensis 9-11 part, Ramulus Cinnamomi 10-14 part, Herba Eupatorii 5-7 part; Radix Paeoniae Rubra 9-11 part, Radix Glycyrrhizae 9-11 part, Radix Boehmeriae 9-11 part, Radix Rehmanniae 13-17 part.
Method for preparing:, and it is carried out sterilization processing with Burdick lamp with all raw materials mix; Then, put people's baking box to pharmaceutical drying, with pulverizer medicine is pulverized, be ground into the powder face then, restir is evenly packed in the hard capsule, packs every 0.5 gram.
Usage and dosage: every day three times, each two hard capsules, oral meal.
The invention has the beneficial effects as follows; Treating both the principal and secondary aspects of a disease, have no side effect, taking convenience, be easy to absorption, instant effect, good effect, price is low, effect is rapid; Meet relevant national standard through check; Confirm instant effect through observation on Clinical Application, compare long-acting, quick-acting and characteristics of high efficiency that the present invention has with the medicine of traditional treatment coronary heart disease.
The specific embodiment
Embodiment 1
The Chinese medicine composition of treatment coronary heart disease of the present invention is processed by the raw material of following weight: Rhizoma Arisaematis 8 grams, Radix Salicis Purpureae 6 grams, Herba Moslae Cavaleriei 8 grams; Radix Rubi Multibracteati 8 grams, the Radix Astragali 14 grams, Pollen Typhae 12 grams, Flos Carthami 9 grams; Rhizoma Chuanxiong 10 grams, Radix Angelicae Sinensis 10 grams, Ramulus Cinnamomi 12 grams, Herba Eupatorii 6 grams; Radix Paeoniae Rubra 10 grams, Radix Glycyrrhizae 10 grams, Radix Boehmeriae 10 grams, the Radix Rehmanniae 15 grams.
Method for preparing:, and it is carried out sterilization processing with Burdick lamp with all raw materials mix; Then, put people's baking box to pharmaceutical drying, with pulverizer medicine is pulverized, be ground into the powder face then, restir is evenly packed in the hard capsule, packs.
Usage and dosage: every day three times, each two hard capsules, oral meal.
Embodiment 2
The Chinese medicine composition of treatment coronary heart disease of the present invention is processed by the raw material of following weight: Rhizoma Arisaematis 7 grams, Radix Salicis Purpureae 5 grams, Herba Moslae Cavaleriei 7 grams; Radix Rubi Multibracteati 7 grams, the Radix Astragali 13 grams, Pollen Typhae 10 grams, Flos Carthami 8 grams; Rhizoma Chuanxiong 9 grams, Radix Angelicae Sinensis 9 grams, Ramulus Cinnamomi 10 grams, Herba Eupatorii 5 grams; Radix Paeoniae Rubra 9 grams, Radix Glycyrrhizae 9 grams, Radix Boehmeriae 9 grams, the Radix Rehmanniae 13 grams.
All the other are identical with embodiment 1.
Embodiment 3
The Chinese medicine composition of treatment coronary heart disease of the present invention is processed by the raw material of following weight: Rhizoma Arisaematis 9 grams, Radix Salicis Purpureae 7 grams, Herba Moslae Cavaleriei 9 grams; Radix Rubi Multibracteati 9 grams, the Radix Astragali 15 grams, Pollen Typhae 14 grams, Flos Carthami 10 grams; Rhizoma Chuanxiong 11 grams, Radix Angelicae Sinensis 11 grams, Ramulus Cinnamomi 14 grams, Herba Eupatorii 7 grams; Radix Paeoniae Rubra 11 grams, Radix Glycyrrhizae 11 grams, Radix Boehmeriae 11 grams, the Radix Rehmanniae 17 grams.
All the other are identical with embodiment 1.
Embodiment 4 clinical observations:
The present invention carries out clinical observation treatment to 400 routine patients, and the age 34 is to 70 years old, male's 180 examples, and women's 220 examples are coronary heart disease.Therapeutic Method: oral, every day three times, each two, one month is a course of treatment.
(1) efficacy assessment standard:
Cure: clinical symptoms signs such as chest pain, uncomfortable in chest, arrhythmia, premature beat, atrial fibrillation disappear, and it is normal that functional activity recovers, and each item inspection index recovers normal.
Effectively: clinical symptoms is clearly better or takes a turn for the better, and each item inspection indexing section normally or normal basically.
Invalid: the clinical symptoms sign does not have improvement, and each item inspection index is still undesired.
(2) therapeutic effect:
Clinical cure 360 examples account for 90%; Effective 40 examples account for 10%; Invalid 0 example, total effective rate 100%.Wherein, cure 80 examples a course of treatment, cure 90 examples two courses of treatment, cure 80 examples three courses of treatment, cure 110 examples four courses of treatment.
Claims (1)
1. Chinese medicine composition of treating coronary heart disease, it is characterized in that: the raw material by following parts by weight is processed: Rhizoma Arisaematis 7-9 part, Radix Salicis Purpureae 5-7 part, Herba Moslae Cavaleriei 7-9 part; Radix Rubi Multibracteati 7-9 part, Radix Astragali 13-15 part, Pollen Typhae 10-14 part, Flos Carthami 8-10 part; Rhizoma Chuanxiong 9-11 part, Radix Angelicae Sinensis 9-11 part, Ramulus Cinnamomi 10-14 part, Herba Eupatorii 5-7 part; Radix Paeoniae Rubra 9-11 part, Radix Glycyrrhizae 9-11 part, Radix Boehmeriae 9-11 part, Radix Rehmanniae 13-17 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110242242A CN102266447B (en) | 2011-08-23 | 2011-08-23 | Chinese medicinal composition for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110242242A CN102266447B (en) | 2011-08-23 | 2011-08-23 | Chinese medicinal composition for treating coronary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102266447A CN102266447A (en) | 2011-12-07 |
| CN102266447B true CN102266447B (en) | 2012-08-29 |
Family
ID=45049028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110242242A Active CN102266447B (en) | 2011-08-23 | 2011-08-23 | Chinese medicinal composition for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102266447B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104435659A (en) * | 2014-09-01 | 2015-03-25 | 周春美 | Traditional Chinese medicine tablet for treating coronary atherosclerotic heart disease and angina pectoris and preparation method of traditional Chinese medicine tablet |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101658636A (en) * | 2009-09-29 | 2010-03-03 | 李宁 | Chinese medical composition for treating coronary heart disease |
-
2011
- 2011-08-23 CN CN201110242242A patent/CN102266447B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101658636A (en) * | 2009-09-29 | 2010-03-03 | 李宁 | Chinese medical composition for treating coronary heart disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102266447A (en) | 2011-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772745B (en) | Chinese medicinal preparation for treating cancer and preparation method thereof | |
| CN102973862A (en) | Chinese medicine preparation for treating skin itch | |
| CN104940810A (en) | Traditional Chinese medicine composition for treating angina | |
| CN101658636B (en) | Chinese medical composition for treating coronary heart disease | |
| CN102552512B (en) | Traditional Chinese medicine used for treating hepatitis B | |
| CN101954042A (en) | Tumor eliminating capsule | |
| CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
| CN102266447B (en) | Chinese medicinal composition for treating coronary heart disease | |
| CN102836338B (en) | Chinese medicament for treating cardia-cerebrovascular diseases | |
| CN102908443A (en) | Medicinal composition for therapy or adjuvant therapy of aids, preparation method of medicinal composition and application of medicinal composition | |
| CN102240383B (en) | Traditional Chinese medicine composition for treating dysmenorrhea | |
| CN102614343A (en) | Medicament for treating dysmenorrhea | |
| CN102526385B (en) | Medicament for treating climacteric syndrome | |
| CN102727773B (en) | Traditional Chinese medicinal capsule for treating blood mucoviscidosis | |
| CN103127413B (en) | Pharmaceutical preparation for treating coronary diseases | |
| CN102805795B (en) | Chinese medicinal composition for treating acute soft tissue injury of chest and hypochondrium and application thereof | |
| CN101612233B (en) | Chinese medicine preparation for detumescence and analgesia | |
| CN102225154B (en) | Medicament composition for treating pulmonary fibrosis | |
| CN101559134A (en) | Chinese materia medica preparation for treating rosacea | |
| CN101653584A (en) | Medicine for treating spondylose cervicale radiculaire | |
| CN101530479B (en) | Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy | |
| CN101537121A (en) | Chinese medicine for treating arteriosclerosis | |
| CN101279069A (en) | Medicament composite for dredging channels and collaterals, and promoting blood-circulation and removing blood stasis, and method of preparing the same | |
| CN1954847A (en) | Medicine for treating psoriasis | |
| CN105125740A (en) | Medicinal preparation for treating cerebral hemorrhage and preparation technology thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Ren Jianjun Inventor after: Gao Zhurong Inventor before: Gao Zhurong |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: GAO ZHURONG TO: REN JIANJUN GAO ZHURONG |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUDONG TECHNOLOGY CENTER Free format text: FORMER OWNER: GAO ZHURONG Effective date: 20131125 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 274400 HEZE, SHANDONG PROVINCE TO: 226400 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20131125 Address after: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong Patentee after: Rudong science and Technology Center Address before: 266 Caoxian traditional Chinese medicine hospital, Zhongxing Road, Shandong, Heze 274400, Caoxian Province, China Patentee before: Gao Zhurong |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200413 Address after: No. 10, Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee after: Rudong industrial and commercial information consulting service center Address before: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong Patentee before: Rudong science and Technology Center |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20211104 Address after: 226400 No.8, wisdom Avenue, Donghu scenic area, Dayu Town, Rudong County, Nantong City, Jiangsu Province Patentee after: Nantong Donghu International Travel Agency Co., Ltd Address before: 226400 No.10 Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee before: Rudong industrial and commercial information consulting service center |
|
| TR01 | Transfer of patent right |